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Imaging techniques are deployed in human subjects
research on an increasingly large scale. Worldwide, images
of the brain, the abdomen or the whole body are acquired in
clinical and population-based cohort studies, and in neu-
roscience, cognitive science and behavioural science
studies. Many of these imaging studies are performed in
volunteers who are presumed healthy and free of any
symptoms. Yet, even in healthy volunteers, structural
abnormalities are detected quite frequently, in approxi-
mately 2–3 % of MRI scans of the brain [1, 2], and pos-
sibly in over a third of whole-body MRI scans [3]. So-
called incidental findings may be of clinical or reproductive
significance to research participants. Incidental findings
have commonly been regarded as findings that are unre-
lated to the aims of the study and are discovered unex-
pectedly in the course of conducting research [4].
The word ‘incidental’ literally means ‘‘being likely to
ensue as a chance or minor consequence’’ or ‘‘occurring
merely by chance or without intention or calculation’’ [5].
Incidental findings have historically been understood as
observations ‘stumbled upon’ by researchers or radiolo-
gists. This presupposes a passive, unprepared observer,
upon whom an abnormality ‘happens’ by chance. The
ethics of incidental findings has generally aligned with this
notion. Ethical guidance on the detection, management and
communication of incidental findings requires researchers
or institutions to have (no more than) a ‘contingency plan’
in place: if researchers stumble upon something that may
be relevant to the health of the participant, then they should
act. Most guidance documents do state that the actions to
be taken (e.g. consultation of an expert radiologist for
confirmation of the finding, communication of the finding
to the participant or their physician) should be outlined in a
predesigned protocol or pathway to be approved by an
institutional review board [4, 6, 7], which should be com-
municated beforehand with research participants. Thus,
current ethical guidance covers mostly what happens after
incidental findings have been detected, but it does not
expressly address whether incidental findings should be
detected or what actions should be taken to avoid or ensure
the detection incidental findings. A prominent topic of
debate is whether routine review of research scans is
required. Practices vary considerably across countries and
studies [7, 8]: among the largest population-based studies
currently being conducted in Europe, approaches for the
detection of incidental findings range from only limited
handling of those findings that are stumbled upon by
radiographers during scan acquisition [9] to having all
scans read by dedicated radiologists [10]. In what follows
we explain why the research community must take a
proactive role and resolve this debate.
Incidental findings are no longer unexpected
As imaging of healthy participants is becoming more
widespread and researchers’ experience with the detection,
management and clinical follow-up of incidental findings is
consequently becoming more thorough, incidental findings
can no longer be considered to be unexpected. The
prevalence of clinically significant incidental findings
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among healthy participants is known to be around 2.7 % in
MRI of the brain [1], which implies a number needed to
scan of around 37 for one significant finding [1, 2]. The
prevalence may be slightly higher in elderly subjects [2],
but even in children and adolescents, incidental findings
occur [11]. Incidental findings may be (much) more fre-
quent in other areas of the body, such as the abdomen or
chest [3, 12]. Based on this accumulating evidence,
researchers can thus anticipate, firstly: that incidental find-
ings will occur; and, secondly, for specified study popula-
tions (i.e. depending on age range, health status): how many
and what types of incidental findings are likely to occur.
Incidental findings are no longer accidental
Incidental findings are the result not of chance, but of
choices made—intentionally or unintentionally—by the
researcher, research team and/or institution. The technical
parameters of the imaging study, the training and instruc-
tion of the research staff, the time and resources spent on
the reviewing of scans, are all factors that will affect the
detection of incidental findings.
First, researchers can influence the occurrence of inci-
dental findings through the design of the scan protocol
itself, through decisions regarding the technical parameters
or the sequences to be acquired and the quality thereof: e.g.
in brain imaging, T2 weighted and fluid-attenuated inver-
sion recovery (FLAIR) images are of greater diagnostic
utility than T1 weighted images or functional MRI and will
generally lead to the detection of more incidental findings
[2, 13].
Second, whether or not incidental findings are detected
depends in part on the person who is looking at the scans.
As radiographers are trained differently from radiologists,
they will perceive different things when looking at the
same scan. Likewise, PhD-researchers in neuroscience or
psychology university departments will perceive differ-
ently from hospital-based research staff, and so on. Not
only the researchers’ background and training, but also
their personality traits (e.g. conscientiousness) or state of
mind (e.g. how much sleep they have had) may affect what
they see when looking at MRI scans.
Third, whether incidental findings are detected depends
on the instructions given to the person who is looking at the
scans: are they asked to only check the quality of the
images or also to check for abnormalities? Are they trained
to review scans for abnormalities? And even: how much
importance is placed on the task of reviewing by supervi-
sors? Does the reviewer have access to expert opinion
when in doubt?
Fourth, what the researcher sees on MRI scans depends
on the time and the timing allocated for (clinical) review of
scans. Are scans reviewed on the spot or later on? Are they
to be glanced over in a few seconds or scrutinized for
minutes? Are those who are asked to review scans allotted
sufficient time or are they working under stress?
Additional factors that can influence the detection of
incidental findings may include the goals of the research
(medical or non-medical), the location of the research
centre (whether the research setting is hospital-based or, for
instance, a neuroscience lab at a psychology department),
and the research population (e.g. healthy student-volun-
teers or the elderly). The same researcher may see differ-
ently when reviewing scans for a medically oriented study
or a study with a different (e.g. behavioural) orientation, in
a hospital-based research setting or in a neuroscience lab.
Context often colours perception.
These and others factors are likely to influence the way
scans are ‘looked at’. Technical and organizational factors
work together to fashion the salience of abnormalities and
therewith to bring about the detection of incidental find-
ings. The occurrence of incidental findings is thus depen-
dent not only on the age and health status of research
participants, but also—and potentially equally or more
so—on choices made by researchers concerning the scan
protocol, the selection and instruction of scanner operators,
and the clinical review (or not) of scans. Incidental findings
are not ‘discovered’ but ‘created’. They are not accidental:
knowingly or unknowingly, they are orchestrated.
Ethical implications
Although incidental findings do not always lead to health
benefits [14] and are associated with risks (e.g. medical
costs, psychological harms and burdens of unnecessary
follow-up testing and overtreatment) [13, 15], it is widely
endorsed that if a researcher detects a finding of clinical
relevance, he or she has a ‘duty to disclose’ the finding to
the participant [6, 7, 16]. We have tried to unravel the black
box of the ‘if’ within that maxim: incidental findings do not
happen accidentally, but are brought about. They are the
result of technical, social and institutional factors that are
controlled by researchers, research teams, institutional
review boards and funding organizations. The research
community should take responsibility for the—control-
lable—factors within the research setting that will affect
the likelihood of detection of incidental findings.
Now what does taking responsibility mean? What
choices—regarding the scan protocol, the staff tasked with
reviewing scans and their training and instruction—should
be made? Are all choices equally justifiable? Given the
variation in research settings, research aims and profes-
sionals involved in research imaging, it will hardly be
possible to formulate a one-size-fits-all recommendation
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for the management of incidental findings. Rather, ethical
guidance should be differentiated across research settings.
We will take routine review of research scans as an
example of how to go about the task of differentiation.
The crucial consideration in the ethics of incidental
findings, we argue, is this: participants’ expectations should
be met—to a reasonable extent. Research participants tend
to trust that abnormalities—if present—will be detected
and communicated to them [15]. A mismatch between
practices of incidental findings and subjects’ expectations
may undermine informed consent and may lead to harm
(e.g. through false reassurance) [17, 18]. Mismatches can
basically be resolved in two ways: first, by ‘lifting up’
research practice (e.g. by indeed offering routine review);
or second, by bringing down participants’ expectations
(e.g. by informing participants about a no-feedback policy).
The latter may be morally unacceptable in some—but not
all—research settings.
Routine clinical review is time-consuming and costly,
and may not be feasible for all research groups or institu-
tions. Some groups may thus decide to instruct radiogra-
phers to review scans on the spot for quality only, and to
avoid the detection of abnormalities. This approach is often
accompanied by an informed consent process in which
participants are told that ‘no one will look at the scans’
and/or that ‘no feedback will be given’. This policy may be
defensible in certain research contexts, for instance, in
neuroscience, cognitive science or behavioural science
laboratories in which studies are conducted, for example,
using fMRI of the brain among healthy student–volunteers.
It is conceivable that in such research contexts, the
informed consent process can be successfully used to
downplay participants’ expectations [19] and to rebut the
so-called diagnostic misconception among participants
[16]. After all, it can be explained that the images acquired
are of limited diagnostic utility: potentially significant
abnormalities can easily be missed (i.e. false negative
errors), even by trained radiologists, while visible abnor-
malities may be artefacts (i.e. false positive errors) [16]. It
would be a waste of resources to have qualified radiologists
review fMR images of the brain acquired for non-medical
research purposes: fMR images lack informative value.
In other research contexts, however, we contend that—
some form of—routine review of research scans is morally
required. For instance, research teams that are hospital-
based, have access to clinical expertise and/or conduct
health-related studies for which sequences of diagnostic
utility are acquired, such as T1 and T2 weighted and/or
FLAIR images, should perform some sort of structured
review for clinically relevant abnormalities. For in such
clearly medical research settings, research participants
will—reasonably—expect obvious and important abnor-
malities to be detected and fed back [15]. Furthermore, the
vast majority of participants of clinical or population-based
cohort studies prefer to know about incidental findings, and
indicate an interest in learning relevant health information
to which they might otherwise not have access [18, 20].
The principle of reciprocity [21] coupled with the—logis-
tically—relative ease with which diagnostic-quality scans
can be checked for apparent abnormalities by trained per-
sonnel, requires researchers to arrange routine review.
Though routine review by a clinical radiologist need not
entail unbearable financial costs [22], less costly pathways
may be feasible, too: research personnel can be trained to
distinguish normal from abnormal scans and to send the
latter on—in a second step–for expert opinion. An expert
radiologist should confirm the clinical significance of an
apparent abnormality before it is fed back to the research
participant [6, 7]. Therefore, researchers should make
arrangements for second-step consultation with expert
radiologists prior to the start of any imaging study. A two-
step approach may be more feasible in some body parts
than others, e.g. brain imaging versus abdominal imaging.
Any selected approach for the handling of incidental
findings should be implemented in a standardized manner,
communicated with research participants as part of the
informed consent process, and monitored through a quality
assurance program.
Routine review of research scans is but one controllable
factor in the ‘creation’ of incidental findings. It is beyond
the scope of this article to outline differentiated ethical
recommendations for all controllable factors in all research
settings.
Conclusion
In the above, we have tried to show that it will no longer
suffice to have established a pathway for when incidental
findings have ‘happened’. Researchers and research insti-
tutions must make up their minds: should they facilitate or
avoid the detection of incidental findings? We have argued
that there is indeed an answer to that question, though it
depends on the research setting. Researchers should plan
ahead and assume their decisive roles in the orchestration
of incidental findings. Ethically responsible pathways for
the detection, management and communication of inci-
dental findings should accommodate research participants’
expectations. In population-based cohort studies of a
clearly medical character or studies in which diagnostic-
quality images are acquired, all research scans should be
reviewed—in one way or another—for relevant
abnormalities.
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